Premium
A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib ( MLN 8237) and Bortezomib in Relapsed Multiple Myeloma
Author(s) -
Rosenthal Allison,
Kumar Shaji,
Hofmeister Craig,
Laubach Jacob,
Vij Ravi,
Dueck Amylou,
Gano Katherine,
Stewart A. Keith
Publication year - 2016
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13765
Subject(s) - bortezomib , multiple myeloma , aurora a kinase , medicine , proteasome inhibitor , cancer research , aurora inhibitor , cancer , cell cycle
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom